CBSC activates China manufacturing pipeline and advances MyCardia AT into final NMPA submission phase with Ebulent Medical.

Jan 15

Cardiac Biotech

Cardiac Biotech

心脏生物科技解决方案激活MyCardia AT中国生产流程并进入NMPA最终申报阶段

CBSC activates China manufacturing pipeline and enters final NMPA submission phase for MyCardia AT cardiac monitoring device.

CBSC secures Health Canada license for CardioHolter AT with $375K order from Your Heart Protector Corp, expanding cardiac monitoring in Canada.

Sep 25

Cardiac Biotech

Cardiac Biotech

心脏生物科技解决方案获得加拿大卫生部MyCardia AT设备许可证

CBSC secures Health Canada license for CardioHolter AT, lands $375K order with Your Heart Protector Corp, expanding into Canadian market.

How can we help you?

Tell us what you are interested in.

Contact Us

订阅我们的新闻邮件！

订阅我们的电子报，我们将直接向您发送最新消息。